Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of alpha7 nicotinic receptors and internalization of NMDA receptors
about
Organophosphates dysregulate dopamine signaling, glutamatergic neurotransmission, and induce neuronal injury markers in striatumCathepsin L plays a role in quinolinic acid-induced NF-Κb activation and excitotoxicity in rat striatal neuronsNicotine attenuates the effect of HIV-1 proteins on the neural circuits of working and contextual memoriesNeuroprotective effects of donepezil against cholinergic depletion.Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism.Methyllycaconitine- and scopolamine-induced cognitive dysfunction: differential reversal effect by cognition-enhancing drugs.Suppression of NMDA receptor function in mice prenatally exposed to valproic acid improves social deficits and repetitive behaviors.Impacts of thyroxine combined with donepezil on hippocampal ultrastructures and expressions of synaptotagmin-1 and SNAP-25 in adult rats with hypothyroidismLipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling.NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease.Role of P-glycoprotein in mediating rivastigmine effect on amyloid-β brain load and related pathology in Alzheimer's disease mouse model.Nicotinic receptors in neurodegeneration.Age-Related Decline in Brain and Hepatic Clearance of Amyloid-Beta is Rectified by the Cholinesterase Inhibitors Donepezil and Rivastigmine in Rats.Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia.Enhancement of nicotinic receptors alleviates cytotoxicity in neurological disease models.Dysregulation of synaptic and extrasynaptic N-methyl-D-aspartate receptors induced by amyloid-β.Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease.Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease.Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients.Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration.Effects of thyroxin and donepezil on hippocampal acetylcholine content and syntaxin-1 and munc-18 expression in adult rats with hypothyroidism.Tropisetron as a neuroprotective agent against glutamate-induced excitotoxicity and mechanisms of action.Concurrent administration of thyroxine and donepezil induces plastic changes in the prefrontal cortex of adult hypothyroid rats.Role of α7- and α4β2-nAChRs in the neuroprotective effect of nicotine in stress-induced impairment of hippocampus-dependent memory.Neuroprotective effects of donepezil against Aβ42-induced neuronal toxicity are mediated through not only enhancing PP2A activity but also regulating GSK-3β and nAChRs activity.Nicotinic acetylcholine receptors mediate donepezil-induced oligodendrocyte differentiation.Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer's disease.Spatiotemporal expression of postsynaptic density 95 in rat retina after optic nerve injury.Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer's disease patients.Donepezil promotes differentiation of neural stem cells into mature oligodendrocytes at the expense of astrogenesis.Donepezil modulates the endogenous immune response: implications for Alzheimer's disease.Downregulation of postsynaptic density-95-interacting regulator of spine morphogenesis reduces glutamate-induced excitotoxicity by differentially regulating glutamate receptors in rat cortical neurons.Screening for Human Milk Amino Acids by HPLC-ESI-MS/MSNeuroprotective Effects of the Multitarget Agent AVCRI104P3 in Brain of Middle-Aged Mice
P2860
Q23918184-4B3CCEB4-F92F-4D92-BFCB-C6F3B0383053Q27305158-22E047D1-10F1-4972-AFBF-B9AEA3D8E424Q30278962-232559FD-18A6-4A2E-8543-75F2F8B69F9BQ30440321-B13C2E5A-A6C8-4AD8-A2BC-93FA61A6AC08Q34061622-A1E82787-CE2E-451E-8D8B-501793A470F6Q34667088-8C584511-29D6-4F35-AC81-AD2121F96BE7Q35650220-DE788A55-79F0-4F87-AEB5-D9BBE629F79AQ35894876-8C198189-754B-4BEA-B501-91FA102F647EQ36052691-7483641F-7B7C-4B61-8D0B-07B9FD2B7344Q36310524-747539C1-207F-41BD-8E62-608BEB67AB81Q36678091-1014ED22-382A-4D61-9031-3592A2419F39Q36828916-5517267C-42FF-4BC7-AE65-3C5D6C256561Q37596042-B280D7EA-0352-47E0-8AB0-DF370A47E0E7Q38066550-B657DD76-D378-45D1-B49B-2672F4403727Q38068415-6EC193F7-2B21-46E0-80CA-EA1D11D25A8EQ38153617-35B48F0E-96D8-495B-81FC-88660DF30498Q38208461-46091F73-96FC-490D-9579-8C399A63A864Q38532889-93C12383-7EB2-4C28-B775-3E545A1CCBCDQ38598430-4F046041-0A36-4F23-881E-A4BB5B2180F7Q38684594-AC574D90-B19C-4C77-8B9B-35375A8C9379Q41942697-812EE446-797A-4E6C-B831-E724675474D7Q42120726-1100A4E7-D412-45CA-9DC8-5A1644923A52Q42546587-F5D1398D-F5BA-4168-9BE0-D0EB98D1D5F5Q43795854-CA5C6C43-F2D1-4F3A-B897-B75CC5F1967FQ46669273-B6CC4389-0069-4BAB-A978-3E411F72C570Q47910897-7349AAE6-56FC-4D25-8DCB-E57E9795E8EFQ48356126-3F584F03-5837-4765-9DA2-FBCC78582AB9Q48891863-80F257AA-7DAD-4983-9CF6-EB3AFD6E26CDQ50588053-FBDEA3AB-A407-48FA-8649-289D4D8B1E5EQ51466628-3545477D-540E-4BE2-B6BC-9BDE736BAD38Q51704620-A20FEF9D-0D71-41B2-9853-D4BFC2E854DBQ53087526-624DA95E-D41B-46DF-8864-114539ECA139Q58524103-1B464778-A90B-4CB6-A64C-AF97D769309AQ58764136-31C239BA-901B-4DCF-89DC-F361F23F5F4A
P2860
Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of alpha7 nicotinic receptors and internalization of NMDA receptors
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Neuroprotection by donepezil a ...... ernalization of NMDA receptors
@ast
Neuroprotection by donepezil a ...... ernalization of NMDA receptors
@en
Neuroprotection by donepezil a ...... ernalization of NMDA receptors
@nl
type
label
Neuroprotection by donepezil a ...... ernalization of NMDA receptors
@ast
Neuroprotection by donepezil a ...... ernalization of NMDA receptors
@en
Neuroprotection by donepezil a ...... ernalization of NMDA receptors
@nl
prefLabel
Neuroprotection by donepezil a ...... ernalization of NMDA receptors
@ast
Neuroprotection by donepezil a ...... ernalization of NMDA receptors
@en
Neuroprotection by donepezil a ...... ernalization of NMDA receptors
@nl
P2093
P2860
P1476
Neuroprotection by donepezil a ...... ernalization of NMDA receptors
@en
P2093
H Sugimoto
S Shimohama
P2860
P304
P356
10.1111/J.1476-5381.2010.00894.X
P407
P577
2010-09-01T00:00:00Z